Results 141 to 150 of about 110,798 (311)
Aggressive prostate cancer is associated with pericyte dysfunction
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero +11 more
wiley +1 more source
Feedback gap and strategies for handling criticism in early surgical career. [PDF]
Pedersen H +5 more
europepmc +1 more source
Activities of the American Legion in textbook analysis and criticism 1938-1951
Orville Eastland Jones
openalex +1 more source
Screening for lung cancer: A systematic review of overdiagnosis and its implications
Low‐dose computed tomography (CT) screening for lung cancer may increase overdiagnosis compared to no screening, though the risk is likely low versus chest X‐ray. Our review of 8 trials (84 660 participants) shows added costs. Further research with strict adherence to modern nodule management strategies may help determine the extent to which ...
Fiorella Karina Fernández‐Sáenz +12 more
wiley +1 more source
Effectiveness of a mobile application the emotion-focused training for helping professionals in reducing compassion fatigue and enhancing compassion satisfaction and resilience. [PDF]
Halamová J, Kanovský M, Blašková LJ.
europepmc +1 more source
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece +18 more
wiley +1 more source
Monetary Authority on literary texts analysis – in the light of cultural criticism
Isthaar Dawood Mohammed
openalex +1 more source
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz +15 more
wiley +1 more source
Improvement in avoidance in major depressive disorder: A 10-month prospective study of depressive symptoms and personality traits. [PDF]
Higuchi R +9 more
europepmc +1 more source

